Daniel C. Javitt, M.D., Ph.D.

Printer-friendly versionPrinter-friendly version
Daniel C. Javitt, M.D., Ph.D.

JOINED THE SCIENTIFIC COUNCIL IN 2010

Professor of Psychiatry and Neuroscience
Director, Division of Experimental Therapeutics
Director, The Silvio O. Conte Center for Schizophrenia Research
Director, Program in Cognitive Neuroscience and Schizophrenia,
Nathan Kline Institute
Columbia University College of Physicians and Surgeons

Dr. Javitt’s research focuses on brain mechanisms underlying negative symptoms and cognitive deficits in schizophrenia, with particular emphasis on NMDA receptors (receptors for glutamate, a neurotransmitter that plays a role in learning and memory), neurophysiological assessment and brain stimulation. Being among the first to demonstrate a link between NMDA receptor dysfunction and schizophrenia, he has recently initiated studies on NMDA receptor antagonists, including ketamine and highdose D-cycloserine, in depression treatment, and of brain stimulation methods, including transcranial direct current stimulation. Dr. Javitt has served for over 15 years as a reviewer for NIH grant applications, and is a former chair of the Brain Disorders and Clinicial Neursocience (BDCN) review committee.

Dr. Javitt received his B.A., magna cum laude, from Princeton in 1979 and his M.D. from Albert Einstein College of Medicine in 1983.

NARSAD Grants: Young Investigator 1990, Independent Investigator 1995